American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
OBJECTIVE
To develop a guideline to improve the accuracy of immunohistochemical (IHC) estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer and the utility of these receptors as predictive markers.


METHODS
The American Society of Clinical Oncology and the College of American Pathologists convened an international Expert Panel that conducted a systematic review and evaluation of the literature in partnership with Cancer Care Ontario and developed recommendations for optimal IHC ER/PgR testing performance.


RESULTS
Up to 20% of current IHC determinations of ER and PgR testing worldwide may be inaccurate (false negative or false positive). Most of the issues with testing have occurred because of variation in preanalytic variables, thresholds for positivity, and interpretation criteria.


CONCLUSIONS
The Panel recommends that ER and PgR status be determined on all invasive breast cancers and breast cancer recurrences. A testing algorithm that relies on accurate, reproducible assay performance is proposed. Elements to reliably reduce assay variation are specified. It is recommended that ER and PgR assays be considered positive if there are at least 1% positive tumor nuclei in the sample on testing in the presence of expected reactivity of internal (normal epithelial elements) and external controls. The absence of benefit from endocrine therapy for women with ER-negative invasive breast cancers has been confirmed in large overviews of randomized clinical trials.
Hammond
M Elizabeth H
ME
Intermountain Healthcare, University of Utah School of Medicine, Salt Lake City, UT, USA. guidelines@asco.org
Hayes
Daniel F
DF
Dowsett
Mitch
M
Allred
D Craig
DC
Hagerty
Karen L
KL
Badve
Sunil
S
Fitzgibbons
Patrick L
PL
Francis
Glenn
G
Goldstein
Neil S
NS
Hayes
Malcolm
M
Hicks
David G
DG
Lester
Susan
S
Love
Richard
R
Mangu
Pamela B
PB
McShane
Lisa
L
Miller
Keith
K
Osborne
C Kent
CK
Paik
Soonmyung
S
Perlmutter
Jane
J
Rhodes
Anthony
A
Sasano
Hironobu
H
Schwartz
Jared N
JN
Sweep
Fred C G
FC
Taube
Sheila
S
Torlakovic
Emina Emilia
EE
Valenstein
Paul
P
Viale
Giuseppe
G
Visscher
Daniel
D
Wheeler
Thomas
T
Williams
R Bruce
RB
Wittliff
James L
JL
Wolff
Antonio C
AC
D005260:Female; D006801:Humans; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology; D019317:Evidence-Based Medicine; D007150:Immunohistochemistry; D008495:Medical Oncology / Q000592:standards; D011237:Predictive Value of Tests; D011960:Receptors, Estrogen / Q000235:genetics / Q000378:metabolism; D011980:Receptors, Progesterone / Q000235:genetics / Q000378:metabolism; D012680:Sensitivity and Specificity; D012955:Societies, Medical; D014481:United States; D000078202:Systematic Reviews as Topic
D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
J Clin Oncol. 1999 May;17(5):1474-81
10334533
Semin Oncol. 2002 Jun;29(3):294-300
12063683
Mod Pathol. 2004 Dec;17(12):1545-54
15272277
J Clin Oncol. 2008 May 20;26(15):2473-81
18487567
J Natl Cancer Inst. 2006 Nov 1;98(21):1571-81
17077359
Breast Cancer. 2004;11(3):267-75
15550845
Int J Cancer. 1999 Jun 21;84(3):203-8
10371334
J Clin Oncol. 2008 Mar 20;26(9):1404-10
18349391
Arch Pathol Lab Med. 2010 Jun;134(6):930-5
20524870
Clin Endocrinol Metab. 1980 Jul;9(2):361-8
6249524
Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):325-31
17721279
Br J Cancer. 1996 Nov;74(9):1445-51
8912543
Int J Cancer. 2000 Mar 20;89(2):111-7
10754487
N Engl J Med. 2004 Dec 30;351(27):2817-26
15591335
Am J Clin Pathol. 2003 Jul;120(1):86-92
12866377
Cancer. 1980 Dec 15;46(12 Suppl):2884-8
7448733
Clin Cancer Res. 2006 Aug 1;12(15):4614-8
16899609
Am J Clin Pathol. 2004 Feb;121(2):172-4
14983929
Histopathology. 2006 Oct;49(4):411-24
16978205
Appl Immunohistochem Mol Morphol. 2008 Dec;16(6):513-20
18931614
Breast. 2002 Oct;11(5):419-29
14965706
Anticancer Res. 2005 May-Jun;25(3c):2535-42
16080489
Breast Cancer. 2006;13(1):74-83
16518065
J Steroid Biochem. 1976 Jun-Jul;7(6-7):505-10
787684
J Clin Oncol. 2007 Jan 1;25(1):118-45
17159189
J Clin Oncol. 2008 Mar 1;26(7):1059-65
18227529
Arch Pathol Lab Med. 2007;131(1):18-43
19548375
Histopathology. 1990 Oct;17(4):319-25
2258170
Adv Anat Pathol. 2005 Jan;12(1):10-9
15614160
J Cell Biochem Suppl. 1994;19:138-45
7823586
Arch Pathol Lab Med. 1985 Aug;109(8):716-21
3893381
J Clin Oncol. 2007 Sep 1;25(25):3846-52
17679725
J Clin Oncol. 2006 Dec 20;24(36):5637-44
17116944